Marburg virus vaccines: comparing classical and new approaches
Open Access
- 16 October 2001
- Vol. 20 (3-4) , 586-593
- https://doi.org/10.1016/s0264-410x(01)00353-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Marburg Virus Vaccines Based upon Alphavirus Replicons Protect Guinea Pigs and Nonhuman PrimatesVirology, 1998
- DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal ChallengeVirology, 1998
- Antigenicity and Vaccine Potential of Marburg Virus Glycoprotein Expressed by Baculovirus RecombinantsVirology, 1997
- Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genesin Vitroand Immunization against Heterologous Pathogensin VivoVirology, 1997
- Characterization of a new Marburg virus isolated from a 1987 fatal case in KenyaPublished by Springer Nature ,1996
- Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeysJournal of Biotechnology, 1996
- MARBURG-VIRUS DISEASE IN KENYAThe Lancet, 1982
- INACTIVATED VACCINE FOR EBOLA VIRUS EFFICACIOUS IN GUINEAPIG MODELThe Lancet, 1980
- Marburg Virus DiseasePublished by Springer Nature ,1971
- Nachweis des „Marburg-Virus” beim PatientenDeutsche Medizinische Wochenschrift (1946), 1968